A recent analysis of AI/ML studies conducted between 2010 and 2023 reveals a significant growth trend, particularly in high-income nations. Out of 3,106 studies examined, a notable portion were FDA-regulated (7.6%) and hospital-sponsored (44.2%). The research also indicated that 12.9% of these studies focused on neoplasms, with enrollment numbers reaching up to 13,977,257 participants. AI
Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →
IMPACT Analysis shows a growth in AI/ML studies, with a focus on specific medical areas and regulatory oversight.
RANK_REASON The cluster reports on a study analyzing trends in AI/ML research, which falls under the research category. [lever_c_demoted from research: ic=1 ai=0.7]
